chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient complained of feeling dizzy, felt hot, tightness in throat and nauseous. Vitals taken twice, patient sat down on edge of cot. Both times vitals were stable. Stated five minutes later that she felt fine, retook vitals, no concerns, patient was discharged by self to home.
5 days after vaccination, developed a rash on face that eventually spread to neck. Rash feels painful like sunburn and is itchy.  Skin is dry and scaly
One week post vaccine, red rash appeared on left upper arm below the injection site near the elbow. Appeared to grow for 3 days before it bagan to fade. Was hot and raised.  Still some discoloration at rash and injection site. Utilized some cortisone cream to help control the symptoms per the Doctors instructions - had typical arm soreness and mild reaction at the inection site (swelling, warm, redness) but I have had continued pain in my upper arm, shoulder and radiating into my neck with no relief from medicine and stretching
No menstruation. Last period started 11/25/2021. For as long as I've been menstruating, I've been 27-29 days, typically a 28 day cycle. This is way out of the norm for me.
12/30 vaccination 12/31 felt incredibly run down, fatigue. I also had extreme SOB. I couldn't get enough air.  Monday/Tuesday - clinic for SOB. Wheezing, crackling sound. Prescribed inhaler which administered ever 2 hours for 8 days. Prescribed Fluticasone propionate.
Patients guardian falsified DOB when registering for vaccination, stating the minor's DOB was 11/19/2002. Guardian, consented to the vaccination. Department of Health verified with statistical records that the patients actual DOB is 11/19/2003 which made the vaccine a contraindication.  No known adverse reactions noted.
Patient came in today 8-19-18 and showed me his right arm where he received the PNEUMOVAX 23 from 8-16-18, it was reddened and swollen to his elbow, and a hard nodule at injection site and had chills and muscle aches, he also received a flu vaccine at the same time in left arm. Patient put an ice pack on it the following morning and took some ibuprofen for the pain, he said he day it is starting to feel better and is still sore.
I have been experiencing heavy and painful  periods since vaccines. Also I began getting head pressure with no pain. I felt my head was being squeezed and then slowly the sensation stopped. I didn?t not get headaches just the pressure. I started feeling this in June after my 2nd dose. The last time I felt this was las month.
Janssen COVID-19 Vaccine EUA Started at 6:30 pm and Fever of 102 by 9:00 pm,  Chills, Diarrhea, Ibuprofen brought down fever,
Double vision Dizzy Elevated Blood Pressure Light sensitivity Fatigue  Symptoms lasted for 10 hours, monitored BP, monitored other symptoms (short naps, kept eyes closed as much as possible, minimal light
Provider ordered FluLaval, intended to give Fluad. Flucelvax was administered.
Hives on torso (hips, underneath breasts, stomach) and elbows. Swollen bottom lip. Sore throat & hoarseness.
On morning of 1/12/21 had a migraine with aura, nausea, and vomiting. caused to miss work, Migraine was only that day. Period began next day. Has since happened every month with period. Have also had extreme dizzy spells when changing head position too quickly, raising up from looking down or lying down. Have seen OBGYN about this and see a Neurologist on 8/19/21 with a referral from OBGYN after the treatment they tried did not help.  I have had chronic migraines for some sometime but have been controlled for with Trokendi for almost 2 years and prior to 4 years ago had been less and could usually be easily treated. Have never experienced the dizziness episodes.
3-4" swelling at inj. site, hot, raised, red, itchy. Hives on arms, legs & torso. - Treated with ATARAX, prednisone & Clobetasol.
Passed out; Sweaty; Slightly feverish; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced LOSS OF CONSCIOUSNESS (Passed out) (seriousness criterion medically significant), HYPERHIDROSIS (Sweaty) and PYREXIA (Slightly feverish). At the time of the report, LOSS OF CONSCIOUSNESS (Passed out), HYPERHIDROSIS (Sweaty) and PYREXIA (Slightly feverish) had resolved.            For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Concomitant medications were not reported.   Description: The patient felt sweaty and slightly feverish all night on 21 April 2021. When he got up to urinate he actually passed out (medically significant) and was on the floor for a few seconds. Later last night, on the same day, he went to drink some water, and passed out again for a few seconds. The patient did not seek any medical attention, and stated that he felt fine now.  No treatment information provided.  The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in response to the event is not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
flu like symptoms for 3 days; Had to be in bed; This case was reported by a pharmacist and described the occurrence of influenza-like symptoms in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms and bedridden. On an unknown date, the outcome of the influenza-like symptoms and bedridden were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms and bedridden to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, after vaccination with 1st dose of shingrix, the patient experienced bad reaction to be in bed with flu like symptoms for 3 days. The patient asked, if there was any statistical studies that proved to have less side effects if wait till 6 months versus 2 months to get 2nd dose of Shingrix.
Local reaction 4 x 4.5 cm; erythematous area with minimal tenderness around the injection site.
Patient started receiving severe pain in left arm after vaccine and cannot lift arm.  He has arm in sling and slight movement today.  He took hydrcodone/apap for the pain.  Contacted Dr. and waiting for call back.
Sudden swelling of tongue, trouble swallowing, jaw locked up, couldn't speak 10 minutes after shot.  Took a benadryl 45 minutes after symptoms began.
80 year old male with hx of anemia, AV endocarditis, s/p mechanical AVR maintained on warfarin, CAD- s/p CABG, mild dementia, Depression, HTN, HLD who was brought to the ER for evaluation of generalized weakness, chills and SOB. The patient is hard of hearing and a vague historian. The patient states he has been feeling weak and experiencing chills. The patient also states he has been feeling SOB and is winded with walking short distances. The patient denies any chest pain.  Patient is COVID POSITIVE.
Patient reports knot in her left arm following vaccination and slowly resolving over 6+ weeks. No treatment administered.
Information has been received from a nurse practitioner (NP) concerning a 14 year old female patient with an allergy to wool, who on 27-DEC-2006 was vaccinated with a dose of Gardasil (Lot # 653735/0688F). Concomitant therapy included DEPO-PROVERA, also administered on 27-DEC-2006. In approximately December 2006 ("since vaccination"), the patient "experienced anemia, dizziness, and heavy menstrual cycles." The NP also stated that the patient reported she "felt like she was going to pass out, but did not report passing out." The NP added that the "patient is receiving iron to treat the anemia." Diagnostic labs were performed (date not specified) including a complete blood count (CBC) (result not provided), hemoglobin 10.8 (unit not provided), and hematocrit 31.7 (unit not provided). At the time of this report, the patient had not recovered. Additional information has been requested. 07/06/07 This is in follow-up to report(s) previously submitted on 3/14/2007. Initial and follow up information has been received from a registered nurse practitioner (NP) concerning a 14 year old female with an allergy to wool, who on 27-DEC-2006 (previously reported as 21-NOV-2006) was vaccinated in the right deltoid, with the first dose of GARDASIL (Lot # 653735/0688F). Concomitant therapy included DEPO-PROVERA, also adminsitered at the same visit. There was no illness at the time of vaccination. On 27-FEB-2007 (previously reported as December 2006, 01-FEB-2007 or "since vaccination"), the patient "experienced anemia, dizziness, and heavy menstrual cycles". The NP also stated that the patient reported she "felt like she was going to pass out, but did not report passing out". The NP added that the "patient is receiving iron to treat the anemia". Diagnostic labs were performed on 23-FEB-2007 including a complete blood count (result not provided), hemoglobin 10.8 (unit not provided), and hematocrit 31.7 (unit not provided). Follow up information received from the nurse practitioner indicated that the patient had also been experiencing lightheadedness. On 14-MAR-2007, additional labs were drawn; hemoglobin 11.3 and hematocrit 34.3 (units not specified). The NP confirmed that the patient had recovered from the events, with the exception of the anemia, which is improving. The patient continues to be treated, and the nurse practitioner added that the patient and her mother feel the anemia was "due to GARDASIL". No further information is expected.
Hearing muffled in left ear.  It feels like waterlogged, but not.  Feels like I can breathe through my left ear.  It is a weird sensation.  I don't want to lose my hearing.
There were no adverse reaction. Patient was given the vaccine after the beyond use date which was 10 weeks of storage in refrigerator.
Information has been received from a registered nurse concerning her daughter, a 17 year old female patient, with a history of a "hive like reaction" after receiving a dose of MMR (vaccine) when she was 1 year old," who on 03-FEB-2007 was vaccinated with the first dose of GARDASIL vaccine (yeast). There was no concomitant medication. Following the vaccination, on 22-FEB-2007, the nurse reported that her daughter developed uveitis with photosensitivity and an itchy rash to her legs, arms and trunk. The nurse confirmed that the uveitis was treated with prednisolone eye drops, and the condition "improved." The nurse stated that the rash on her daughter's legs, arms and trunk had not resolved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/14/2007. Initial and follow up information has been received from a registered nurse(RN) and a certified physician's assistant (PAC) , concerning the RN's  daughter, 1 17 year old female student, with a history of "hive like reaction" after receiving a dose of MMR vaccine when she as 1 year old, who on 11-JAN-2007 (reported by the mother on 03-FEB-2007) was vaccinated with the first dose of GARDASIL vaccine (yeast) ( Lot # 654885/1424F). There was no concomitant medication. The PAC indicated the patient was seen on the day of vaccination, 11-JAN-2007, for treatment of conjuntivitis and questioned possible adenovirus. The PAC reported the patient developed uveitis with photosensitivity, and an itchy rash to her legs, arms and trunk. She confirmed that the diagnosis of uveitis was made bya an optometrist who had seen her daughter. The nurse stated that the uveitis was treated with PRED-FORTE eye drops for 10 days on a tapering dose. The PAC confirmed that on 26-FEB-2007, the patient had the following diagnostic tests: complete blood count with differential, normal; erythrocyte sedimentation rate 3mm/hour; antinuclear antibodies ELISA screen, negative; and rheeumatoid factor screen, <3 IU/ml. Follow up information from the mother of the patient, indicated that "one week after discontinuing the prednisolone drops, her daughter "got photosensitive again." The mother then took her daughter toa an ophthalmologist, whom she reported was "tending toward  keratitis." Keratitis was also confirmed by the PAC. The patient was again  treated with prednisolone. The PAC confirmed that at the time of this report, the patient had recovered from the events (date  not specified). No further information is expected.
About 1 hour after receiving the vaccines the clinet returned with his parent. He had swelling and redness in the right arm and complained of severe pain at injection site.
30 y.o. female who was seen at a COVID Vaccine Clinic today for her first dose of the COVID 19 vaccination.    She denied any history of previous adverse reactions to vaccines.   She was given the Moderna vaccination in the left deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience Right arm pain, numbness/tingling and soreness, note that injection was given in left arm.  She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to abdominal pain, blood pressure abnormality , chest pain, collapse, drooling, hypotension, increased swelling, rapid progression of symptoms, respiratory distress, skin changes, tongue swelling and vomiting.     ALLERGY REVIEW OF SYSTEMS:  Patient complains of muscle aches (Right arm)         Previous Reactions: No previous reactions to vaccines.     Objective    Vitals Vitals:   01/15/21 1239 01/15/21 1248 BP: 137/89 134/89 Pulse: 99 100 SpO2: 100% 100%     Blood Sugar 66 collected at 1236 * Patient given snack (granola bar) just before blood glucose checked.      Physical Exam Constitutional:      General: She is not in acute distress.    Appearance: Normal appearance. She is not ill-appearing.  Cardiovascular:     Rate and Rhythm: Normal rate.  Pulmonary:     Effort: Pulmonary effort is normal. No respiratory distress.  Musculoskeletal:     Right shoulder: She exhibits pain. She exhibits normal range of motion and no tenderness.     Right elbow: She exhibits normal range of motion and no swelling. No tenderness found.     Right wrist: She exhibits normal range of motion and no tenderness.  Skin:    General: Skin is warm and dry.  Neurological:     Mental Status: She is alert and oriented to person, place, and time.        Assessment/Plan  Treatment included: Ibuprofen/analgesics. Follow up response to treatment: no change. Patient discharge: Stable to go home and follow up with PCP.   Reports that she had work up for Guillain Barre 2.5 years ago but this was ruled out. States that she has had intermittent pain of all extremities since that time and has a handicap parking placard due to this. She denies any pain in right arm prior to the vaccine but states it started just a few minutes after administration. She has full ROM without difficulty and full sensation but reports some numbness and tingling as well as soreness but not necessarily tender to touch. Ibuprofen was administered but shortly after patient requesting to leave and feels this pain is the same as what she's had over the past 2.5 years but wanted to keep us aware. She will be discharging home and states she does not live alone.
Rash on injection site, large area of upper arm inflamed for approx 4 days
Information has been received from a Licensed Practitioner Nurse, concerning a 15 year old female patient, whose mother told the LPN that she had a history of chicken pox some time prior to 04-SEP-2007 who had a Varicella Zoster AB (IGG) lab test drawn on 04-SEP-2007 and the lab result was 0.13 and was negative, no known allergies, who was vaccinated with a dose of VARIVAX (Merck) (Lot # 1861U, Lot # also reported as 0524X) 0.5 mL SQ in the right arm on 27-MAY-2008 and had a negative varicella titer. There was no concomitant medication. The patient has not experienced any known symptoms. The patient did not seek medical attention. There was no product quality complaint. The patient previously received the following vaccinations: On 18-AUG-1993, 20-NOV-1993, 05-FEB-1994, 09-MAR-1995 and 16-JUN-1998 was vaccinated with Tdap. On 27-MAY-2008, was vaccinated with the first dose of Hep A and on an unknown date the second dose of Hep A. On an unknown date, the patient was vaccinated with MCV. On 26-NOV-1993, 05-FEB-1994, 04-APR-1994 and 19-SEP-1994 was vaccinated with HIB (unspecified carrier). On 08-JUL-1993, 17-SEP-1993, 04-APR-1994 and 24-JUN-2008, the patient was vaccinated with Hep B. On 18-AUG-1993, 18-OCT-1993 and 09-MAR-1994, was vaccinated with IPV (unspecified). On 19-SEP-1994 and 05-MAR-1998, was vaccinated with MMR. On 03-AUG-1996, was vaccinated with DT. On 22-JUL-2008, the patient was vaccinated with the second dose of VARIVAX (Merck) (Lot #661445/0525X). The nurse reported that she did not known if the patient had gone for a Varicella- Zoster AB (IGG) lab test after the first or second dose of VARIVAX. On 05-JUN-2002 and 07-JUN-2005, the patient was vaccinated with tuberculin purified protein derivative. Additional information is expected.
Itching in scalp (hives), neck stiffness, soreness, nausea, swollen lips, and hives on eyes and body.
Varicella administered R upper arm, after a few minutes later client slumped over, non responsive, body, arms became rigid, hand fisted with some tremors, back arched backwards, client laid on floor, breathing during whole event. Emesis x1, client opened eyes and became responsive, responding to questions. Ambulance came with EMTS, client taken to Emergency Room.
I noticed that there was some vaccine leakage at the site after the needle was removed.; Vaccine underdose; No adverse event; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT LEAKAGE (I noticed that there was some vaccine leakage at the site after the needle was removed.), UNDERDOSE (Vaccine underdose) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT LEAKAGE (I noticed that there was some vaccine leakage at the site after the needle was removed.), UNDERDOSE (Vaccine underdose) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT LEAKAGE (I noticed that there was some vaccine leakage at the site after the needle was removed.), UNDERDOSE (Vaccine underdose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      Concomitant Medication use information was not provided by reporter.  Treatment Medication use information was not provided by reporter.
Fever; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (Headache) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis (Moderate to severe ).   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (Headache) outcome was unknown.            No relevant concomitant medications were reported. No treatment medication reported. It was unknown if patient was enrolled in a COVID-19 vaccine trial.  The reporter's causality for the event(s) of fever, nausea and headache with Humira was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Information has been received from a registered nurse (R.N) concerning a 60 year old female patient who on 15-OCT-2010 was vaccinated into her right deltoid with a 0.5mL dose of PNEUMOVAX 23 (lot number 664653/1337Y; expiration date: 03-MAR-2011). The nurse stated that the patient experienced pain and swelling at the injection site. On 19-OCT-2010 patient was seen at the doctor's office and on 20-OCT-2010 she went to the emergency room. The patient was treated with antibiotic and released (she was not hospitalized). At the time of report, the patient's outcome was unknown. This is one of several reports from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information is not expected.
12/03/1997 fever 3 days, eyes puffy, fussy, mild cough, runny nose, puss very early peril orb cellulitis, augment in. 12/10/1997 5 days diaper rash, red scrotum and pus, s dellitis lesions, candid diaper rash, nystatin cream. 12/12/1999, Hypotonia throughout extremities and trunk, 7/01/1999, Speech, hearing, intuening, poor eye contact concerns. 98/11/1999, Autism, significant delay in speech.
Hospitalized (10.27.21);  COVID-19 positive (10.30.21);  fully vaccinated    Admission Date: 10/27/2021 Date of Death: 11/2/21 Time of Death:  1:30 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Closed displaced intertrochanteric fracture of left femur, initial encounter (HCC) [S72.142A] Closed left hip fracture, initial encounter (HCC) [S72.002A] Hypotension [I95.9]   HOSPITAL COURSE: The patient was admitted to the hospital on 10/27 after sustaining a fall.  He subsequently was found to have a closed left hip fracture and underwent a cephalomedullary nail fixation on 10/28.  He subsequently developed anemia and hypotension postop as well as testing positive for COVID-19.  Over the next 2-3 days the patient remained on high-flow nasal cannula due to COVID-19 and was unable to be weaned.  Discussion with family and the patient today led to them wanting to pursue comfort care due to the patient's continued respiratory decline.  The patient was placed in comfort care and started on a morphine infusion.  The patient then subsequently passed away peacefully at 1:30 p.m.